GlassScriptPhysician profile
Iliana Doycheva
NPI 1659520534
$980.33
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2023: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $163.21 | 2019 | |
| Exelixis INC. | $161.30 | 2019 | |
| Abbott Laboratories | $152.70 | 2023 | Freestyle Libre 3 |
| Abbvie INC. | $139.61 | 2019 | |
| Dova Pharmaceuticals | $120.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.36 | 2019 | |
| Shionogi INC | $55.05 | 2019 | |
| Ucb, INC. | $46.06 | 2019 | |
| Amgen INC. | $20.76 | 2019 | |
| Beta Bionics, INC. | $16.30 | 2023 | Ilet Bionic Pancreas |
| Genzyme Corporation | $14.10 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iliana Doycheva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.